John Conley, Mark Lotz, Stelios Papadopoulos, Sir Edwin Southern, Mike Catelani, Chris Johnson, and Robert Wicke

Mar 05, 2004

Premium

Alnylam CFO John Conley has resigned his position from the company, according to a recent Alnylam filing with the US Securities and Exchange Commission.

According to Alnylam, Conley’s departure became effective Jan. 31. Additional details were unavailable.

Mark Lotz has become vice president for regulatory affairs of MediciNova, the company said last week. Prior to joining the company, he worked as executive director of regulatory affairs at Isis Pharmaceuticals.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Menu